Ivan M. Lieberburg
Ivan M. Lieberburg publishes mostly in Molecular Biology, Physiology and Pharmacology, on topics such as Alzheimer's disease research and treatments, Prion Diseases and Protein Misfolding and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #55,478 of 7,710,434 ranked researchers
- Rank in United States
- #21,430 of 1,627,098
- Works
- 110
- Citations
- 34k
- Citations per work
- 307.3
What does Ivan M. Lieberburg research?
Ivan M. Lieberburg's work is mostly in Medicine (35%), Biochemistry, Genetics and Molecular Biology (29%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4036.2%
- Health Sciences3834.6%
- Medicine3834.6%
- Life Sciences3229.2%
- 1Molecular Biology23% of their works
- 2Physiology20% of their works
- 3Pharmacology6% of their works
- 4Genetics6% of their works
- 5Endocrinology, Diabetes and Metabolism4% of their works
- 6Psychiatry and Mental health4% of their works
Research topics
- Alzheimer's disease research and treatments
- Prion Diseases and Protein Misfolding
- Cholinesterase and Neurodegenerative Diseases
- Estrogen and related hormone effects
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Neuroendocrine regulation and behavior
- Computational Drug Discovery Methods
- Dementia and Cognitive Impairment Research
Which keywords describe Ivan M. Lieberburg's research?
The keywords of their largest research topics: Amyloid Hypothesis, Tau Pathology, Neurodegenerative Diseases, Alzheimer's Disease, Molecular Basis, Prion Diseases, Acetylcholinesterase and Cholinesterase Inhibitors.
- Mild Cognitive Impairment
- Virtual Screening
- Social Behavior
- Transthyretin
- Receptor
- Cholinesterase Inhibitors
- Prion Diseases
- Alzheimer's Disease
- Tau Pathology
- Amyloid Hypothesis
- Neurodegenerative Diseases
- Molecular Basis
- Acetylcholinesterase
- Estrogen
- Cardiac Amyloidosis
- Oxytocin
- Molecular Docking
- Dementia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Amyloid Hypothesis601 topic
- Tau Pathology601 topic
- Neurodegenerative Diseases432 topics
- Alzheimer's Disease292 topics
- Molecular Basis231 topic
- Prion Diseases231 topic
- Acetylcholinesterase201 topic
- Cholinesterase Inhibitors201 topic
- Estrogen161 topic
- Receptor161 topic
- Cardiac Amyloidosis151 topic
- Transthyretin151 topic
- Oxytocin121 topic
- Social Behavior121 topic
- Molecular Docking111 topic
- Virtual Screening111 topic
- Dementia91 topic
- Mild Cognitive Impairment91 topic
Where does Ivan M. Lieberburg work?
Ivan M. Lieberburg's main affiliation in the publication record is Athena Group (United States), United States.
How many publications and citations does Ivan M. Lieberburg have?
OpenAlex counts 110 works and 33,799 citations for Ivan M. Lieberburg, an h-index of 60, ranking #55,478 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ivan M. Lieberburg. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.